Researchers will compare combinations of antimicrobials to identify the most effective combination for use in a novel, aerosolized, nanoparticle drug delivery system.

Researchers will study subpopulations of immune cells in the blood of horses to discover new strategies to help horses fight off equine herpesvirus infections.

Researchers will investigate a genetic predisposition in Friesian horses to an eye disorder, bilateral corneal stromal loss, which can cause vision loss.

Researchers will evaluate the effects of increased weight loads carried by horses to provide science-based recommendations to the equine industry and address potential welfare concerns.

Using cultured cells, researchers will study how the horse's immune system responds to endotoxins, toxic substances in bacteria responsible for many horse diseases, including gastrointestinal disease and foal sepsis.

Researchers will evaluate the effectiveness of a new surgical suture technique to improve upper airway function in horses with recurrent laryngeal neuropathy, a common upper respiratory disease in horses.

Researchers will improve the quality of the feline genome assembly, an important tool for studying genetic causes and risks associated with diseases in cats.

Researchers will investigate the effectiveness of a new anticoagulant drug to prevent abnormal and deadly blood clotting complications in cats with heart disease.

Researchers will investigate the effectiveness of the antiviral drug famciclovir to treat and control infectious upper-respiratory disease associated with feline herpesvirus in shelter cats.

Researchers will investigate the effectiveness of a contraceptive vaccine to manage overpopulation of free-roaming cats.